The APC Anti-Human CD56 Antibody (B-A19) is a valuable tool for researchers studying immune cell populations and their role in immune responses. CD56, also known as neural cell adhesion molecule (NCAM), is a marker commonly used to identify natural killer cells and a subset of T cells.This antibody, conjugated to allophycocyanin (APC), provides a highly sensitive and specific method for detecting CD56 expression in human samples. Its bright fluorescence signal allows for accurate flow cytometry analysis, making it an excellent choice for immunophenotyping studies and identifying CD56-expressing cell populations.
With its high reactivity and specificity, the APC Anti-Human CD56 Antibody (B-A19) is an essential tool for research in immunology, oncology, and infectious diseases. By targeting CD56, researchers can gain valuable insights into immune cell function, disease mechanisms, and potential therapeutic targets.
Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum:
Swissprot:
P51677
Gene ID:
4684
Storage Buffer:
Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Stability & Storage:
Keep as concentrated solution. Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase.
Background:
CD56 is a single transmembrane glycoprotein also known as NCAM (neural cell adhesion molecule), Leu-19, or NKH1. It is a member of the Ig superfamily. The 140 kD isoform is expressed on NK and NKT cells. CD56 is also expressed in the brain (cerebellum and cortex) and at neuromuscular junctions. Certain large granular lymphocyte (LGL) leukemias, small-cell lung carcinomas, neuronal derived tumors, myelomas, and myeloid leukemias also express CD56. CD56 plays a role in homophilic and heterophilic adhesion via binding to itself or heparan sulfate.